Mycoses surgeries are the root cause of fungal skin infections caused by fungi and primarily caused by three groups of fungi: dermatophytes, yeasts and moldsare. Mycoses are caused due to weakened immune systems, i.e., immunocompromised state that includes patients with HIV/AIDS and patients being treated with corticosteroids for a prolonged period. Globally, increasing prevalence of AIDS/HIV and weakened immune systems, Large Population Base, rising awareness regarding Mycoses, and Recent development in technology are the prime growth drivers of global Mycoses market. In addition, increase in adoption of Mycoses treatment, and emerging economies such as China, India and others, will create new opportunities for global Mycoses market. However, higher cost of the research and development, and risk of side effects are the key restraints for global Mycoses market.
Geographically North America dominated global Mycoses market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Europe is projected to have fastest growth, owing to rapidly increasing prevalence AIDS/HIV, leading to weakened commune system, Population’s changing life style and environment, and modernization of healthcare infrastructure. Among all the types, Dermatophytes has the highest market share in global Mycoses market due to higher prevalence of low immune patients across the globe.
This report identifies the global Mycoses market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Mycoses market.
This report segments global Mycoses market on the basis of type of fungi, treatment, and regional market as follows:
This report identifies all the major companies operating in the Mycoses market. Some of the major companies’ profiles in detail are as follows:
Geographically North America dominated global Mycoses market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Europe is projected to have fastest growth, owing to rapidly increasing prevalence AIDS/HIV, leading to weakened commune system, Population’s changing life style and environment, and modernization of healthcare infrastructure. Among all the types, Dermatophytes has the highest market share in global Mycoses market due to higher prevalence of low immune patients across the globe.
This report identifies the global Mycoses market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Mycoses market.
This report segments global Mycoses market on the basis of type of fungi, treatment, and regional market as follows:
- Mycoses Market, By Type of Fungi: dermatophytes, yeasts and molds, others
- The report has focused study on Mycoses market by basis of treatment such as: Photodynamic, Radiation, Chemotherapy, Targeted, Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the Mycoses market. Some of the major companies’ profiles in detail are as follows:
- Bayer AG
- Dr. Reddy's Laboratories Limited
- Merck & Co., Inc
- Pacgen Biopharmaceuticals Corporation
- Quinnova Pharmaceuticals, Inc
1. Mycoses Market – Market Overview
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Mycoses Market– Market Forces
4.1. Drivers
4.1.1. Increasing prevalence of AIDS/HIV and weakened immune systems
4.1.2. Large Population Base
4.1.3. Recent development in technology
4.2. Restraints
4.2.1. Higher cost of research and development
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Mycoses Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Mycoses Market, By Type of Fungi
6.1. Dermatophytes
6.2. Yeasts
6.3. Molds
6.4. others
7. Mycoses Market, By Treatment
7.1. Photodynamic therapy
7.2. Radiation therapy
7.3. Chemotherapy
7.4. Targeted therapy
7.5. Drug Medication
8. Mycoses Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW
9. Mycoses – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Bayer AG
10.2. Dr. Reddy's Laboratories Limited
10.3. Helix BioMedix, Inc
10.4. Merck & Co., Inc
10.5. Pfizer, Inc
10.6. Nuvo Research, Inc
10.7. Moberg Derma AB
10.8. Novabiotics Ltd
10.9. Pacgen Biopharmaceuticals Corporation
10.10. Quinnova Pharmaceuticals, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Mycoses Market– Market Forces
4.1. Drivers
4.1.1. Increasing prevalence of AIDS/HIV and weakened immune systems
4.1.2. Large Population Base
4.1.3. Recent development in technology
4.2. Restraints
4.2.1. Higher cost of research and development
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Mycoses Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Mycoses Market, By Type of Fungi
6.1. Dermatophytes
6.2. Yeasts
6.3. Molds
6.4. others
7. Mycoses Market, By Treatment
7.1. Photodynamic therapy
7.2. Radiation therapy
7.3. Chemotherapy
7.4. Targeted therapy
7.5. Drug Medication
8. Mycoses Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW
9. Mycoses – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Bayer AG
10.2. Dr. Reddy's Laboratories Limited
10.3. Helix BioMedix, Inc
10.4. Merck & Co., Inc
10.5. Pfizer, Inc
10.6. Nuvo Research, Inc
10.7. Moberg Derma AB
10.8. Novabiotics Ltd
10.9. Pacgen Biopharmaceuticals Corporation
10.10. Quinnova Pharmaceuticals, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
List of Tables:
Table 1: Mycoses Market Overview 2023-2030
Table 2: Mycoses Market Leader Analysis 2023-2030 (US$)
Table 3: Mycoses Market Product Analysis 2023-2030 (US$)
Table 4: Mycoses Market End User Analysis 2023-2030 (US$)
Table 5: Mycoses Market Patent Analysis 2013-2023* (US$)
Table 6: Mycoses Market Financial Analysis 2023-2030 (US$)
Table 7: Mycoses Market Driver Analysis 2023-2030 (US$)
Table 8: Mycoses Market Challenges Analysis 2023-2030 (US$)
Table 9: Mycoses Market Constraint Analysis 2023-2030 (US$)
Table 10: Mycoses Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Mycoses Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Mycoses Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Mycoses Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Mycoses Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Mycoses Market Value Chain Analysis 2023-2030 (US$)
Table 16: Mycoses Market Pricing Analysis 2023-2030 (US$)
Table 17: Mycoses Market Opportunities Analysis 2023-2030 (US$)
Table 18: Mycoses Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Mycoses Market Supplier Analysis 2023-2030 (US$)
Table 20: Mycoses Market Distributor Analysis 2023-2030 (US$)
Table 21: Mycoses Market Trend Analysis 2023-2030 (US$)
Table 22: Mycoses Market Size 2023 (US$)
Table 23: Mycoses Market Forecast Analysis 2023-2030 (US$)
Table 24: Mycoses Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 26: Mycoses Market By Type of Fungi, Revenue & Volume,By Dermatophytes, 2023-2030 ($)
Table 27: Mycoses Market By Type of Fungi, Revenue & Volume,By Yeasts, 2023-2030 ($)
Table 28: Mycoses Market By Type of Fungi, Revenue & Volume,By Molds, 2023-2030 ($)
Table 29: Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 30: Mycoses Market By Treatment , Revenue & Volume,By Photodynamic therapy, 2023-2030 ($)
Table 31: Mycoses Market By Treatment , Revenue & Volume,By Radiation therapy, 2023-2030 ($)
Table 32: Mycoses Market By Treatment , Revenue & Volume,By Chemotherapy, 2023-2030 ($)
Table 33: Mycoses Market By Treatment , Revenue & Volume,By Targeted therapy , 2023-2030 ($)
Table 34: Mycoses Market By Treatment , Revenue & Volume,By Drug Medication, 2023-2030 ($)
Table 35: North America Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 36: North America Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 37: South america Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 38: South america Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 39: Europe Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 40: Europe Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 41: APAC Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 42: APAC Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 43: Middle East & Africa Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 44: Middle East & Africa Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 45: Russia Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 46: Russia Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 47: Israel Mycoses Market, Revenue & Volume,By Type of Fungi, 2023-2030 ($)
Table 48: Israel Mycoses Market, Revenue & Volume,By Treatment , 2023-2030 ($)
Table 49: Top Companies 2023 (US$)Mycoses Market, Revenue & Volume
Table 50: Product Launch 2023-2030Mycoses Market, Revenue & Volume
Table 51: Mergers & Acquistions 2023-2030Mycoses Market, Revenue & Volume
List of Figures:
Figure 1: Overview of Mycoses Market 2023-2030
Figure 2: Market Share Analysis for Mycoses Market 2023 (US$)
Figure 3: Product Comparison in Mycoses Market 2023-2030 (US$)
Figure 4: End User Profile for Mycoses Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Mycoses Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Mycoses Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Mycoses Market 2023-2030
Figure 8: Ecosystem Analysis in Mycoses Market2023
Figure 9: Average Selling Price in Mycoses Market 2023-2030
Figure 10: Top Opportunites in Mycoses Market 2023-2030
Figure 11: Market Life Cycle Analysis in Mycoses Market
Figure 12: GlobalBy Type of FungiMycoses Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Treatment Mycoses Market Revenue, 2023-2030 ($)
Figure 14: Global Mycoses Market - By Geography
Figure 15: Global Mycoses Market Value & Volume, By Geography, 2023-2030 ($)
Figure 16: Global Mycoses Market CAGR, By Geography, 2023-2030 (%)
Figure 17: North America Mycoses Market Value & Volume, 2023-2030 ($)
Figure 18: US Mycoses Market Value & Volume, 2023-2030 ($)
Figure 19: US GDP and Population, 2023-2030 ($)
Figure 20: US GDP – Composition of 2023, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2023-2030 ($)
Figure 22: Canada Mycoses Market Value & Volume, 2023-2030 ($)
Figure 23: Canada GDP and Population, 2023-2030 ($)
Figure 24: Canada GDP – Composition of 2023, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 26: Mexico Mycoses Market Value & Volume, 2023-2030 ($)
Figure 27: Mexico GDP and Population, 2023-2030 ($)
Figure 28: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 30: South America Mycoses Market South America 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil Mycoses Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil GDP and Population, 2023-2030 ($)
Figure 33: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 35: Venezuela Mycoses Market Value & Volume, 2023-2030 ($)
Figure 36: Venezuela GDP and Population, 2023-2030 ($)
Figure 37: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 39: Argentina Mycoses Market Value & Volume, 2023-2030 ($)
Figure 40: Argentina GDP and Population, 2023-2030 ($)
Figure 41: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 43: Ecuador Mycoses Market Value & Volume, 2023-2030 ($)
Figure 44: Ecuador GDP and Population, 2023-2030 ($)
Figure 45: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 47: Peru Mycoses Market Value & Volume, 2023-2030 ($)
Figure 48: Peru GDP and Population, 2023-2030 ($)
Figure 49: Peru GDP – Composition of 2023, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 51: Colombia Mycoses Market Value & Volume, 2023-2030 ($)
Figure 52: Colombia GDP and Population, 2023-2030 ($)
Figure 53: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica Mycoses MarketCosta Rica 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica GDP and Population, 2023-2030 ($)
Figure 57: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 59: Europe Mycoses Market Value & Volume, 2023-2030 ($)
Figure 60: U.K Mycoses Market Value & Volume, 2023-2030 ($)
Figure 61: U.K GDP and Population, 2023-2030 ($)
Figure 62: U.K GDP – Composition of 2023, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 64: Germany Mycoses Market Value & Volume, 2023-2030 ($)
Figure 65: Germany GDP and Population, 2023-2030 ($)
Figure 66: Germany GDP – Composition of 2023, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 68: Italy Mycoses Market Value & Volume, 2023-2030 ($)
Figure 69: Italy GDP and Population, 2023-2030 ($)
Figure 70: Italy GDP – Composition of 2023, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 72: France Mycoses Market Value & Volume, 2023-2030 ($)
Figure 73: France GDP and Population, 2023-2030 ($)
Figure 74: France GDP – Composition of 2023, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2023-2030 ($)
Figure 76: Netherlands Mycoses Market Value & Volume, 2023-2030 ($)
Figure 77: Netherlands GDP and Population, 2023-2030 ($)
Figure 78: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 80: Belgium Mycoses Market Value & Volume, 2023-2030 ($)
Figure 81: Belgium GDP and Population, 2023-2030 ($)
Figure 82: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 84: Spain Mycoses Market Value & Volume, 2023-2030 ($)
Figure 85: Spain GDP and Population, 2023-2030 ($)
Figure 86: Spain GDP – Composition of 2023, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 88: Denmark Mycoses Market Value & Volume, 2023-2030 ($)
Figure 89: Denmark GDP and Population, 2023-2030 ($)
Figure 90: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 92: APAC Mycoses Market Value & Volume, 2023-2030 ($)
Figure 93: China Mycoses Market Value & Volume, 2023-2030
Figure 94: China GDP and Population, 2023-2030 ($)
Figure 95: China GDP – Composition of 2023, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2023-2030 ($)Mycoses Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 97: Australia Mycoses Market Value & Volume, 2023-2030 ($)
Figure 98: Australia GDP and Population, 2023-2030 ($)
Figure 99: Australia GDP – Composition of 2023, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 101: South Korea Mycoses Market Value & Volume, 2023-2030 ($)
Figure 102: South Korea GDP and Population, 2023-2030 ($)
Figure 103: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 105: India Mycoses Market Value & Volume, 2023-2030 ($)
Figure 106: India GDP and Population, 2023-2030 ($)
Figure 107: India GDP – Composition of 2023, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2023-2030 ($)
Figure 109: Taiwan Mycoses Market Taiwan 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 110: Taiwan GDP and Population, 2023-2030 ($)
Figure 111: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 113: Malaysia Mycoses Market Malaysia 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 114: Malaysia GDP and Population, 2023-2030 ($)
Figure 115: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong Mycoses Market Hong Kong 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong GDP and Population, 2023-2030 ($)
Figure 119: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 121: Middle East & Africa Mycoses Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 122: Russia Mycoses Market Russia 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 123: Russia GDP and Population, 2023-2030 ($)
Figure 124: Russia GDP – Composition of 2023, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 126: Israel Mycoses Market Value & Volume, 2023-2030 ($)
Figure 127: Israel GDP and Population, 2023-2030 ($)
Figure 128: Israel GDP – Composition of 2023, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 130: Entropy Share, By Strategies, 2023-2030* (%)Mycoses Market
Figure 131: Developments, 2023-2030*Mycoses Market
Figure 132: Company 1 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 133: Company 1 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 134: Company 1 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 135: Company 2 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 136: Company 2 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 137: Company 2 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 138: Company 3 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 139: Company 3 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 140: Company 3 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 141: Company 4 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 142: Company 4 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 143: Company 4 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 144: Company 5 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 145: Company 5 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 146: Company 5 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 147: Company 6 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 148: Company 6 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 149: Company 6 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 150: Company 7 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 151: Company 7 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 152: Company 7 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 153: Company 8 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 154: Company 8 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 155: Company 8 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 156: Company 9 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 157: Company 9 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 158: Company 9 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 159: Company 10 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 160: Company 10 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 161: Company 10 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 162: Company 11 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 163: Company 11 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 164: Company 11 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 165: Company 12 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 166: Company 12 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 167: Company 12 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 168: Company 13 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 169: Company 13 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 170: Company 13 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 171: Company 14 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 172: Company 14 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 173: Company 14 Mycoses Market Net Sales Share, By Geography, 2023 (%)
Figure 174: Company 15 Mycoses Market Net Revenue, By Years, 2023-2030* ($)
Figure 175: Company 15 Mycoses Market Net Revenue Share, By Business segments, 2023 (%)
Figure 176: Company 15 Mycoses Market Net Sales Share, By Geography, 2023 (%)